The role of a newly identified SET domain-containing protein, SETD3, in oncogenesis.
about
Expression of histone methyltransferases as novel biomarkers for renal cell tumor diagnosis and prognostication.Cell cycle-dependent degradation of the methyltransferase SETD3 attenuates cell proliferation and liver tumorigenesis.Chromatin associated SETD3 negatively regulates VEGF expression.Writing, erasing and reading histone lysine methylations.Phenotypic characterization of SETD3 knockout DrosophilaLong Non-Coding RNAs Guide the Fine-Tuning of Gene Regulation in B-Cell Development and Malignancy
P2860
The role of a newly identified SET domain-containing protein, SETD3, in oncogenesis.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
The role of a newly identified SET domain-containing protein, SETD3, in oncogenesis.
@ast
The role of a newly identified SET domain-containing protein, SETD3, in oncogenesis.
@en
type
label
The role of a newly identified SET domain-containing protein, SETD3, in oncogenesis.
@ast
The role of a newly identified SET domain-containing protein, SETD3, in oncogenesis.
@en
prefLabel
The role of a newly identified SET domain-containing protein, SETD3, in oncogenesis.
@ast
The role of a newly identified SET domain-containing protein, SETD3, in oncogenesis.
@en
P2093
P2860
P1433
P1476
The role of a newly identified SET domain-containing protein, SETD3, in oncogenesis
@en
P2093
Catherine T Yan
Sawanee S Viboolsittiseri
Zhangguo Chen
P2860
P304
P356
10.3324/HAEMATOL.2012.066977
P50
P577
2012-10-12T00:00:00Z